Comet assay in reconstructed 3D human epidermal skin models-investigation of intra- And inter-laboratory reproducibility with coded chemicals

Mutagenesis

Volumn 28, Issue 6, 2013, Pages 709-720

  Reus, Astrid A ^a   Reisinger, Kerstin ^b   Downs, Thomas R ^c   Carr, Gregory J ^c   Zeller, Andreas ^e   Corvi, Raffaella ^d   Krul, Cyrille A M ^a   Pfuhler, Stefan ^c  

^a TNO   (Netherlands)

^b HENKEL KGAA   (Germany)

^c PROCTER AND GAMBLE COMPANY   (United States)

^d JOINT RESEARCH CENTRE   (Italy)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINOTOLUENE; 4 NITROPHENOL; 4 NITROQUINOLINE 1 OXIDE; ACETONE; CARCINOGEN; CYCLOHEXANONE; DNA; ETHYLNITROSOUREA; MESYLIC ACID; METHYL METHANE SULFONATE; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CELL LOSS; CELL SUSPENSION; CHEMICAL SAFETY; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; EPIDERMIS; EPIDERMIS CELL; GENOTOXICITY; HUMAN; HUMAN CELL; IMAGE RECONSTRUCTION; IN VITRO STUDY; IN VIVO STUDY; INTERLABORATORY REPRODUCIBILITY; INTRALABORATORY REPRODUCIBILITY; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; SKIN CULTURE; THREE DIMENSIONAL IMAGING;

4-NITROQUINOLINE-1-OXIDE; COMET ASSAY; CYCLOHEXANONES; DNA DAMAGE; DRUG EVALUATION, PRECLINICAL; EPIDERMIS; ETHYLNITROSOUREA; HUMANS; LABORATORY PROFICIENCY TESTING; METHYL METHANESULFONATE; MODELS, BIOLOGICAL; MUTAGENS; NITROPHENOLS; PHENYLENEDIAMINES; REPRODUCIBILITY OF RESULTS; TISSUE CULTURE TECHNIQUES;

EID: 84888635665     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/get051     Document Type: Article

References (45)

1. Kirkland, D., Aardema, M., Henderson, L. and Muller, L. (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256.
2. Kirkland, D., Aardema, M., Muller, L. and Makoto, H. (2006) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat. Res., 608, 29-42.
3. Kirkland, D., Pfuhler, S., Tweats, D., et al. (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat. Res., 628, 31-55.
4. Matthews, E. J., Kruhlak, N. L., Cimino, M. C., Benz, R. D. and Contrera, J. F. (2006) An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Regul. Toxicol. Pharmacol., 44, 83-96.
5. EC 1907/2006. (2006) Regulation (EC) No 1907/2006 of the European Parliament and the Council of 18 December 2006, concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), establishing a European Chemical Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/03 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EC, 93/67/EC, 93/105/EC and 2000/21/EC. Official J. Eur. Union, 49, 1-849.
6. 2003/15/EC. (2003) Directive 2003 of the European Parliament and of the Council of 27 February 2003, amending Council Directive 76/78/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official J. Eur. Union, 66, 26-35.
7. Pfuhler, S., Kirst, A., Aardema, M., et al. (2010) A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis. Regul. Toxicol. Pharmacol., 57, 315-324.
8. Pfuhler, S., Fellows, M., van Benthem, J., et al. (2011) In vitro genotoxicity test approaches with better predictivity: summary of an IWGT workshop. Mutat. Res., 723, 101-107.
9. Gotz, C., Pfeiffer, R., Tigges, J., et al. (2012) Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes. Exp. Dermatol., 21, 364-369.
10. Hu, T., Khambatta, Z. S., Hayden, P. J., et al. (2010) Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. Toxicol. In Vitro, 24, 1450-1463.
11. Netzlaff, F., Lehr, C. M., Wertz, P. W. and Schaefer, U. F. (2005) The human epidermis models EpiSkin, SkinEthic and EpiDerm: An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur. J. Pharm. Biopharm., 60, 167-178.
12. Kandarova, H., Liebsch, M., Spielmann, H., et al. (2006) Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431. Toxicol. In Vitro, 20, 547-559.
13. Kidd, D. A., Johnson, M. and Clements, J. (2007) Development of an in vitro corrosion/irritation prediction assay using the EpiDerm skin model. Toxicol. In Vitro, 21, 1292-1297.
14. Alepee, N., Tornier, C., Robert, C., Amsellem, C., Roux, M. H., Doucet, O., Pachot, J., Meloni, M. and de Brugerolle de Fraissinette, A. (2010) A catchup validation study on reconstructed human epidermis (SkinEthic RHE) for full replacement of the Draize skin irritation test. Toxicol. In Vitro, 24, 257-266.
15. Kandarova, H., Hayden, P., Klausner, M., Kubilus, J., Kearney, P. and Sheasgreen, J. (2009) In vitro skin irritation testing: Improving the sensitivity of the EpiDerm skin irritation test protocol. Altern. Lab. Anim., 37, 671-689.
16. Jirova, D., Kejlova, K., Bendova, H., Ditrichova, D. and Mezulanikova, M. (2005) Phototoxicity of bituminous tars-correspondence between results of 3T3 NRU PT, 3D skin model and experimental human data. Toxicol. In Vitro, 19, 931-934.
17. Lelievre, D., Justine, P., Christiaens, F., Bonaventure, N., Coutet, J., Marrot, L. and Cotovio, J. (2007) The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol. In Vitro, 21, 977-995.
18. dos Santos, G. G., Spiekstra, S. W., Sampat-Sardjoepersad, S. C., Reinders, J., Scheper, R. J. and Gibbs, S. (2011) A potential in vitro epidermal equivalent assay to determine sensitizer potency. Toxicol. In Vitro, 25, 347-357.
19. Teunis, M., Corsini, E., Smits, M., et al. (2013) Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. Toxicol. In Vitro, 27, 1135-1150.
20. Burlinson, B. (2012) The in vitro and in vivo comet assays. Methods Mol. Biol. 817, 143-163.
21. Tice, R. R., Agurell, E., Anderson, D., et al. (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen., 35, 206-221.
22. Curren, R. D., Mun, G. C., Gibson, D. P. and Aardema, M. J. (2006) Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). Mutat. Res. 607, 192-204.
23. Flamand, N., Marrot, L., Belaidi, J. P., Bourouf, L., Dourille, E., Feltes, M. and Meunier, J. R. (2006) Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: Towards new tools for in vitro risk assessment of dermally applied compounds? Mutat. Res. 606, 39-51.
24. Aardema, M. J., Barnett, B. C., Khambatta, Z., et al. (2010) International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: Transferability and reproducibility. Mutat. Res., 701, 123-131.
25. Aardema, M. J., Barnett, B. B., Mun, G. C., Dahl, E. L., Curren, R. D., Hewitt, N. J. and Pfuhler, S. (2013) Evaluation of chemicals requiring metabolic activation in the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res., 750, 40-49.
26. Dahl, E. L., Curren, R., Barnett, B. C., et al. (2011) The reconstructed skin micronucleus assay (RSMN) in EpiDerm™: detailed protocol and harmonized scoring atlas. Mutat. Res., 720, 42-52.
27. Hu, T., Kaluzhny, Y., Mun, G. C., Barnett, B., Karetsky, V., Wilt, N., Klausner, M., Curren, R. D. and Aardema, M. J. (2009) Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res., 673, 100-108.
28. Mun, G. C., Aardema, M. J., Hu, T., Barnett, B., Kaluzhny, Y., Klausner, M., Karetsky, V., Dahl, E. L. and Curren, R. D. (2009) Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. Mutat. Res., 673, 92-99.
29. Kirkland, D., Kasper, P., Muller, L., Corvi, R. and Speit, G. (2008) Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: A follow-up to an ECVAM workshop. Mutat. Res., 653, 99-108.
30. Hsu, T., Savaraji, N., Trizna, Z., Feun, L., Furlong, C., Schantz, S. and Shirley, L. (1993) Cytogenetic studies on the in-vitro genotoxicity of 4-nitroquinoline- 1-oxide on human-lymphocytes. Int. J. Oncol., 3, 823-826.
31. Searle, C. E. and Woodhouse, D. L. (1963) The carcinogenicity and reactivity to tissue constituents of 4-nitroquinoline-n-oxide. Acta Unio Int. Contra Cancrum, 19, 519-521.
32. Stankowski, L. F. Jr, Roberts, D. J., Chen, H., Lawlor, T., McKeon, M., Murli, H., Thakur, A. and Xu, Y. (2011) Integration of Pig-a, micronucleus, chromosome aberration, and Comet assay endpoints in a 28-day rodent toxicity study with 4-nitroquinoline-1-oxide. Environ. Mol. Mutagen., 52, 738-747.
33. Singh, N. P., McCoy, M. T., Tice, R. R. and Schneider, E. L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191.
34. Montgomery, D. C. (2005) Design and Analysis of Experiments. 6th edn. John Wiley and Sons, Inc., New York, pp. 80-83.
35. Dunnett, W. C. (1955) A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc., 50, 1096-1121.
36. Reus, A. A., Usta, M. and Krul, C. A. (2012) The use of ex vivo human skin tissue for genotoxicity testing. Toxicol. Appl. Pharmacol., 261, 154-163.
37. Schafer-Korting, M., Mahmoud, A., Lombardi Borgia, S., Bruggener, B., Kleuser, B., Schreiber, S. and Mehnert, W. (2008) Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation. Altern. Lab. Anim., 36, 441-452.
38. Wiren, K., Frithiof, H., Sjoqvist, C. and Loden, M. (2009) Enhancement of bioavailability by lowering of fat content in topical formulations. Br. J. Dermatol., 160, 552-556.
39. Nishikawa, T., Haresaku, M., Adachi, K., Masuda, M. and Hayashi, M. (1999) Study of a rat skin in vivo micronucleus test: data generated by mitomycin C and methyl methanesulfonate. Mutat. Res., 444, 159-166.
40. Nishikawa, T., Haresaku, M., Fukushima, A., Nakamura, T., Adachi, K., Masuda, M. and Hayashi, M. (2002) Further evaluation of an in vivo micronucleus test on rat and mouse skin: results with five skin carcinogens. Mutat. Res., 513, 93-102.
41. Cheung, Y. L., Snelling, J., Mohammed, N. N., Gray, T. J. and Ioannides, C. (1996) Interaction with the aromatic hydrocarbon receptor, CYP1A induction, and mutagenicity of a series of diaminotoluenes: implications for their carcinogenicity. Toxicol. Appl. Pharmacol., 139, 203-211.
42. Citro, G., Galati, R., Verdina, A., Marini, S., Zito, R. and Giardina, B. (1993) Activation of 2, 4-diaminotoluene to proximate carcinogens in vitro, and assay of DNA adducts. Xenobiotica, 23, 317-325.
43. La, D. K. and Froines, J. R. (1994) Formation and removal of DNA adducts in Fischer-344 rats exposed to 2, 4-diaminotoluene. Arch. Toxicol., 69, 8-13.
44. Hartmann, A., Agurell, E., Beevers, C., et al. (2003) Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis, 18, 45-51.
45. Vasquez, M. Z. (2012) Recommendations for safety testing with the in vivo comet assay. Mutat. Res., 747, 142-156.